Home/Filings/4/0001140361-14-044896
4//SEC Filing

SKYSTAR BIO-PHARMACEUTICAL CO 4

Accession 0001140361-14-044896

CIK 0001076939operating

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 3:23 PM ET

Size

6.5 KB

Accession

0001140361-14-044896

Insider Transaction Report

Form 4
Period: 2014-12-10
Transactions
  • Purchase

    Common Stock

    2014-12-10$4.56/sh+103,016$469,753313,220 total(indirect: By LLC)
Holdings
  • Common Stock

    193,500
  • Common Stock

    (indirect: By Kingsway Charities, Inc.)
    466,000
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.37 to $4.6499 inclusive. The reporting person undertakes to provide the Issuer, any stockholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

SKYSTAR BIO-PHARMACEUTICAL CO

CIK 0001076939

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001076939

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 3:23 PM ET
Size
6.5 KB